Article Index

Why The High Cost Of Publicly Funded Cancer Drugs?

Why The High Cost Of Publicly Funded Cancer Drugs?Patients with prostate cancer in England and Wales will now have early access to abiraterone, a drug which can delay the need for chemotherapy. The drug previously cost £3,000 a month, and was not considered “cost-effective” for the NHS until cancers were more advanced – even though patients in Scotland had access to it.


FOLLOW INNERSELF

google-plus-iconfacebook-icontwitter-iconrss-icon

 Get The Latest By Email

{emailcloak=off}